Your browser doesn't support javascript.
loading
Addressing the Data Gaps on Child and Adolescent Tuberculosis.
Verkuijl, Sabine; Sekadde, Moorine Penninah; Dodd, Peter J; Arinaitwe, Moses; Chiang, Silvia S; Brands, Annemieke; Viney, Kerri; Sismanidis, Charalambos; Jenkins, Helen E.
Afiliação
  • Verkuijl S; Global Tuberculosis Programme, World Health Organization, 1211 Geneva, Switzerland.
  • Sekadde MP; National Tuberculosis and Leprosy Programme, Kampala 7025, Uganda.
  • Dodd PJ; School of Health and Related Research, University of Sheffield, Sheffield S1 4DA, UK.
  • Arinaitwe M; National Tuberculosis and Leprosy Programme, Kampala 7025, Uganda.
  • Chiang SS; Department of Pediatrics, Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
  • Brands A; Center for International Health Research, Rhode Island Hospital, Providence, RI 02903, USA.
  • Viney K; Global Tuberculosis Programme, World Health Organization, 1211 Geneva, Switzerland.
  • Sismanidis C; Global Tuberculosis Programme, World Health Organization, 1211 Geneva, Switzerland.
  • Jenkins HE; Global Tuberculosis Programme, World Health Organization, 1211 Geneva, Switzerland.
Pathogens ; 11(3)2022 Mar 14.
Article em En | MEDLINE | ID: mdl-35335677
ABSTRACT
The burden of tuberculosis (TB) among children and young adolescents (<15 years old) is estimated at 1.1 million; however, only 400,000 are treated for TB, indicating a large gap between the number who are cared for and the number estimated to have TB. Accurate data on the burden of pediatric TB is essential to guide action. Despite several improvements in estimating the burden of pediatric TB in the last decade, as well as enhanced data collection efforts, several data gaps remain, both at the global level, but also at the national level where surveillance systems and collaborative research are critical. In this article, we describe recent advances in data collection and burden estimates for TB among children and adolescents, and the remaining gaps. While data collection continues to improve, burden estimates must evolve in parallel, both in terms of their frequency and the methods used. Currently, at the global level, there is a focus on age-disaggregation of TB notifications, the collection of data on TB-HIV, multi-drug resistant (MDR)-TB and treatment outcomes, as well as estimates of the disease burden. Additional data from national surveillance systems or research projects on TB meningitis, as well as other forms of extra-pulmonary TB, would be useful. We must capitalize on the current momentum in child and adolescent TB to close the remaining data gaps for these age groups to better understand the epidemic and further reduce morbidity and mortality due to TB.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article